"Magnetic" beta amyloid 1-40 (Aβ1-40) immunomagnetic reduction detection reagent - Taiwan Registration e259c3586adac214bb9755fa900644cc
Access comprehensive regulatory information for "Magnetic" beta amyloid 1-40 (Aβ1-40) immunomagnetic reduction detection reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number e259c3586adac214bb9755fa900644cc and manufactured by MAGQU CO., LTD.. The authorized representative in Taiwan is MAGQU CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Product Details
At present, this product can only be used as one of the reference materials for clinical diagnosis of Alzheimer's disease, and the results of this test cannot be used as the only basis for diagnosis. This product uses immunomagnetic reduction analysis to quantitatively detect the concentration of Aβ1-40 protein in human plasma, and its concentration value needs to be compared with the ratio of the "magnetic amount" beta amyloid 1-42 (Aβ1-42) immunomagnetic reduction test dose (Aβ1-42/Aβ1-40) as the detection value, and with clinical data and other test results, as a reference to assist in the diagnosis of Alzheimer's disease.
C Immunology and microbiology
C.9999 Miscellaneous
QMS/QSD;; 國產
Dates and Status
Dec 08, 2020
Dec 08, 2025